2 months | 30M | Topical finasteride/minoxidil 1/15/2026
A 30-year-old man shares his positive experience with a topical solution containing 0.1% finasteride, 7.5% minoxidil, tretinoin, caffeine, and fluocinolone acetonide after experiencing side effects from oral finasteride and no results from 5% minoxidil. He reports noticeable hair growth in two months with minimal side effects, attributing success to the new topical combination.
View this post in the Community →
Similar Community Posts Join
5 / 5 resultscommunity Topical Dutasteride 1% - High dosage?
User asks about two topical dutasteride solutions and wonders if 1% concentration is overkill compared to 0.1%. They also consider trying standard topical dutasteride before using Minoxidil.
community Topical 7% Min and 0.005% Fin. Should I consider tretinoin, cetirizine, melatonin, caffeine?
The user resumed using topical 5% minoxidil after experiencing hair shedding and is now considering adding topical 7% minoxidil with 0.005% finasteride. They are seeking advice on whether to add tretinoin, cetirizine, melatonin, or caffeine to their regimen, with concerns about tretinoin's sensitivity to sunlight.
community What should you look for when buying topical Finasteride?
Topical Finasteride is most effective at 0.1-0.25%, and Minoxidil at 5%. Tretinoin is optional, and additional ingredients like biotin, caffeine, and saw palmetto are recommended.
community ISO a topical without minoxidil
A user seeks a topical hair loss treatment without minoxidil, considering options like finasteride, dutasteride, caffeine, tretinoin, or prostaglandin analogues. Recommendations include products like Strut, Maximus, Zeuss, and custom formulas from compounding pharmacies.
community 2 month progress shots topical min/fin
A user shared their positive experience with a hair loss treatment using a compounded topical solution of Minoxidil, finasteride, tretinoin, and caffeine, along with ketoconazole shampoo, pumpkin seed oil, zinc, biotin, and microneedling. They reported noticeable hair regrowth and no negative side effects.
Related Research
6 / 6 results
research Treatments for Androgenetic Alopecia and Alopecia Areata
This review discusses current and emerging drug therapies for treating androgenetic alopecia and alopecia areata, and reports no clinical results; it highlights a need for improved and novel treatments.
research Topically used herbal products for the treatment of hair loss: preclinical and clinical studies
This review summarizes preclinical and clinical information on herbal products for hair loss treatment, highlighting their mechanisms, follicular penetration, and potential side effects, suggesting they may offer alternatives to synthetic drugs with fewer side effects.
research A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review
This review discusses current topical treatments, natural products, and complementary therapies for androgenetic alopecia, but it reports no new clinical results.
research Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men – short version
This guideline review by the European Dermatology Forum evaluates current treatments for androgenetic alopecia but reports no new research findings, aiming to assist dermatologists in selecting safe and effective therapies.
research A decade of progress in androgenetic alopecia management: Emerging therapies and multimodal strategies
This review reports that the treatment of androgenetic alopecia is shifting from single therapies to personalized, multimodal approaches incorporating both traditional and emerging pharmacologics, regenerative strategies, nutraceuticals, cosmeceuticals, and device-based interventions, with combination regimens showing improved outcomes.
research Androgenetic Alopecia: An Evidence-Based Treatment Update
This review concluded that oral finasteride for men and topical minoxidil for both genders have the most evidence supporting their effectiveness and safety for treating androgenetic alopecia.